Codes / ICD10CM / B57.41

B57.41 Meningitis in Chagas' disease

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Meningitis in Chagas' disease

Summary

Meningitis in Chagas' disease is a rare complication of the parasitic infection caused by Trypanosoma cruzi, where inflammation of the meninges occurs. This condition arises during the acute or chronic phases of Chagas' disease and may involve the central nervous system. Transmission is primarily through contact with infected triatomine bug feces, though other routes like blood transfusion or congenital transmission are possible.

Causes

The infection is caused by Trypanosoma cruzi, a protozoan parasite. Meningitis develops when the parasite invades the meninges, leading to inflammation. Transmission occurs when the parasite enters the body through breaks in the skin or mucous membranes, often via contact with infected triatomine bug feces. Other routes include blood transfusion, organ transplantation, congenital transmission from an infected mother, or ingestion of contaminated food or drink.

Risk Factors

  • Residence in or travel to endemic regions (e.g., parts of Latin America).
  • Exposure to triatomine bugs in rural or poorly constructed housing.
  • Blood transfusion or organ transplantation from an infected donor.
  • Congenital transmission from an infected mother.
  • Lack of vector control measures in endemic areas.

Symptoms

  • Severe headache.
  • Fever.
  • Stiff neck.
  • Sensitivity to light (photophobia).
  • Nausea or vomiting.
  • Altered mental status or confusion.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, followed by laboratory tests to detect Trypanosoma cruzi in blood or cerebrospinal fluid (CSF). CSF analysis may show elevated white blood cells, increased protein, and low glucose. Serological tests or PCR for parasite DNA can confirm the infection. Imaging studies like MRI or CT scans may be used to assess nervous system involvement.

Treatment Options

Treatment focuses on antiparasitic therapy (e.g., benznidazole or nifurtimox) to eliminate the parasite, combined with supportive care for meningitis symptoms. Corticosteroids may be used to reduce inflammation. In severe cases, hospitalization for intravenous fluids, pain management, and monitoring is necessary.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment. With prompt therapy, recovery is possible, but delayed treatment may lead to long-term neurological damage. Follow-up includes monitoring for recurrence of symptoms and assessing for other complications of Chagas' disease, such as cardiac or gastrointestinal issues.

Complications

  • Permanent neurological damage.
  • Seizures.
  • Cognitive impairment.
  • Increased risk of other Chagas' disease complications (e.g., cardiomyopathy).

Lifestyle & Prevention

  • Avoid exposure to triatomine bugs by using insect screens, bed nets, and insect repellent.
  • Practice good hygiene and food safety in endemic areas.
  • Screen blood donors and organ recipients in high-risk regions.
  • Seek medical care if traveling to or living in endemic areas and experiencing symptoms.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, stiff neck, or confusion, especially if there is a history of exposure to Chagas' disease or travel to endemic regions.

Tips for Medical Coders

Document the presence of meningitis and its association with Chagas' disease clearly. Ensure the code B57.41 is used when meningitis is a specified complication of Chagas' disease. Include details on the phase of Chagas' disease (acute or chronic) and any confirmatory diagnostic tests to support the diagnosis.

Book a walkthrough

B57.41 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.